Published By: Tenable
Published Date: Mar 07, 2018
"Learn how you can accelerate development and strengthen security – without disrupting your operations.
Organizations that effectively meld DevOps and InfoSec can shift security from an afterthought to an integrated, automated, and proactive practice. By reading this paper from IDG, you’ll learn three reasons why DevOps is a game-changer for security and steps you can take foster a more collaborative and proactive approach to securing your enterprise. Topics covered include:
- Adapting security testing tools and processes to the developer
- Automating security into the CI/CD toolchain
- The impact of secure DevOps on your bottom line
- Increasing security awareness and commitment across teams
This paper provides high-level guidance for DevOps and InfoSec professionals seeking collaborative, efficient approaches for strengthening application and information security."
NSS Labs performed an independent test of the Trend Micro Deep Discovery Inspector Model 4000 (Hardware model 4100) v3.8 SP5 and OfficeScan (OSCE) v12.0.1807. The product was subjected to thorough testing at the NSS facility in Austin, Texas, based on the Breach Detection Systems (BDS) Test Methodology v4.0 available at www.nsslabs.com. This test was conducted free of charge and NSS did not receive any compensation in return for Trend Micro’s participation.
While the companion Comparative Reports on security, performance, and total cost of ownership (TCO) will provide information about all tested products, this Test Report provides detailed information not available elsewhere.
Published By: Tricentis
Published Date: Nov 15, 2018
The following maturity model is designed to help you assess your team’s progress on the journey to BDD maturity. This guide will give you a framework for understanding where your team is now on the road to BDD maturity and help you chart a direct course for taking it to the next level. The transition to BDD often comes with significant bumps in the road, but in our experience it is well worth the effort. Teams with mature BDD practices report higher levels of collaboration across functions and also tend to be more advanced in their DevOps release processes. By shifting testing left with BDD, these teams are delivering faster without sacrificing quality.
By downloading this ebook, you will learn:
o Five BDD maturity levels based on the adoption patterns we’ve seen among our user base and the industry at large
o Strategies for achieving the significant process changes that BDD requires, both within and outside the QA team
o Where your team is today and the milestones that will get you
This flash provides an overview of how CA ARCserve® Backup r12 provides several new disaster recovery enhancements, including an easy-to-use Disaster Recovery wizard. Together with the replication and application failover functionality in CA XOsoft™ Replication and CA XOsoft™ High Availability, and the integrity testing features in CA XOsoft™ Assured Recovery, these tools enable you to recover servers, applications, and data swiftly and effectively.
Whether you’re in retail, manufacturing, warehouse management, transportation or healthcare, a mobility solution is a great way to empower your employees to do more. But maximizing the value and success of your mobility solution hinges on one critical decision: choosing the right mobile devices. This white paper takes a look at how choosing the TC51/TC56 for a mobility solution can have a significant impact on the overall success of your initiative.
Detecting and preventing errors that threaten patient safety is a closed-loop process that begins at the point of care, extends to independent laboratories, and then back to the caregiver. Sample identification and results reporting errors can lead to misdiagnosis and inappropriate treatment with deadly consequences. A 2006 Wall Street Journal article reported that while malpractice claims for pathology errors are relatively low, they are the second most costly. In addition to creating a serious risk to patient safety, sample misidentification creates significant financial implications. Redraws, retesting and additional treatment that result from sample errors cost the healthcare industry an estimated
$200 million to $400 million per year.